SEC Filings
Beta Bionics Drops Its 2028 Cash-Runway Date After $161.3 Million Stock Sale
The iLet pump maker's new 10-Q promises cash only "for the foreseeable future" while a securities class action proceeds.
Beta Bionics (BBNX) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
The iLet pump maker's new 10-Q promises cash only "for the foreseeable future" while a securities class action proceeds.
Earnings
Third-quarter sales rose 30% to $35.5 million, but the loss widened and the 2026 revenue outlook narrowed to $124 million to $126 million.
SEC Filings
The filing lists 8,943,061 shares, with a health sciences fund holding a slice, as a securities class action against the company is pending.